share_log
Breakings ·  Oct 1 03:19
FDA: Traditional Approval to Selpercatinib for Adult & Pediatric Patients 2 Years of Age & Older With Advanced or Metastatic Mtc With Ret Mutation
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment